Respiratory viral infections and disease severity in hospitalized children: A preimmunoprophylaxis baseline study highlighting the role of human metapneumovirus

This publication has 29 references indexed in Scilit:

• Effectiveness of a targeted infant RSV immunization strategy (2024–2025): A multicenter matched case-control study in a high-surveillance setting
  Journal of Infection, 2025
• Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis
  The Lancet Child & Adolescent Health, 2025
• Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
  JAMA Pediatrics, 2025
• Human Metapneumovirus: an emerging respiratory pathogen and the urgent need for improved Diagnostics, surveillance, and vaccine development
  Infectious Diseases, 2025
• Clinical Outcomes of Respiratory Syncytial Virus Infection Among Pediatric Immunocompromised Hosts
  Pediatric Blood & Cancer, 2024
• Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the Pneumonia Etiology Research for Child Health (PERCH) study experience
  Clinical Microbiology and Infection, 2024
• Pediatric Respiratory Syncytial Virus Hospitalizations and Respiratory Support After the COVID-19 Pandemic
  JAMA Network Open, 2024
• Factors Associated With Prolonged Respiratory Virus Detection From Polymerase Chain Reaction of Nasal Specimens Collected Longitudinally in Healthy Children in a US Birth Cohort
  Journal of the Pediatric Infectious Diseases Society, 2024
• Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data
  The Lancet, 2024
• Respiratory viral infections in infants with possible sepsis
  Journal of Medical Virology, 2018